MedTrace Logo

Evaluation of the Consumption of a Probiotic on the Load of S. Agalactiae.

NCT04165551 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2020-05-13

No results posted yet for this study

Summary

The objective of this study is to evaluate the effects of oral administration of Lactobacillus BSL\_PS71 on the presence of S. agalactiae in vaginal microbiota of healthy women.

Conditions

  • Streptococcus Agalactiae

Interventions

BIOLOGICAL

Probiotic

Volunteers will take 1 capsule a day of the Probiotic during lunch without any restrictions on diet or lifestyle.

BIOLOGICAL

Placebo

Volunteers will take 1 capsule a day of the Placebo during lunch without any restrictions on diet or lifestyle.

Sponsors & Collaborators

  • Federico García García, PhD

    collaborator UNKNOWN

  • Biosearch S.A.

    lead INDUSTRY

Principal Investigators

  • Federico García, PhD · Head of the Microbiology Service at the San Cecilio Hospital (Granada, Spain)

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2020-09-01
Completion
2020-09-10

Countries

  • Spain

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04165551 on ClinicalTrials.gov